June 1, 2020Open Access

Barriers and facilitators for screening and treatment of hyperlipidemia among patients with inflammatory arthritis

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Patients with IA identified educational needs about IA, increased CVD risk in IA and the need for improved doctor-patient communication about screening for hyperlipidemia and its treatment. Patients were receptive to working with peer coaches to facilitate achievement of these goals.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Navarro‐Millán et al. (Mon,) studied this question.

synapsesocial.com/papers/69d8d8a8b0225cae72bedddb https://doi.org/https://doi.org/10.1186/s41927-020-00123-w

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events2015 · 323 citations
2Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial2017 · 78 citations
3Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups2007 · 41,951 citations
4Patient education on cardiovascular aspects of rheumatoid disease: an unmet need2007 · 33 citations
5Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study2009 · 70 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo